Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Depascale

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Rheumatology (Oxford, England)|January 25, 2022
Whipple's aortitisRoberto Depascale, Marco Pizzi, Roberto Padoan
Autoimmunity Reviews|August 25, 2023
When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients?Ioannis Parodis, Roberto Depascale, Andrea Doria, et al.
Best Practice & Research. Clinical Rheumatology|August 25, 2023
Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosusMariele Gatto, Roberto Depascale, Ana Luisa Stefanski, et al.
Mediterranean Journal of Rheumatology|August 28, 2024
Evolving Concepts in Treat-to-Target Strategies for Systemic Lupus ErythematosusDionysis Nikolopoulos, Maria Helena Lourenço, Roberto Depascale, et al.
Journal of Clinical Medicine|June 27, 2024
Modern Management of Pregnancy in Systemic Lupus Erythematosus: From Prenatal Counseling to Postpartum SupportAnna Gamba, Margherita Zen, Roberto Depascale, et al.
Expert Opinion on Biological Therapy|February 25, 2021
Belimumab: a step forward in the treatment of systemic lupus erythematosusRoberto Depascale, Mariele Gatto, Margherita Zen, et al.
Clinical Rheumatology|August 28, 2024
Effectiveness and safety of low dose Rituximab as remission-maintenance treatment for patients with refractory idiopathic inflammatory myopathies: results of a retrospective study from a monocentric cohortAnna Gamba, Roberto Depascale, Elisabetta Zanatta, et al.
International Journal of Molecular Sciences|February 25, 2023
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial HypertensionBeatrice Moccaldi, Laura De Michieli, Marco Binda, et al.
Therapeutic Advances in Musculoskeletal Disease|October 7, 2021
Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren's syndrome: a literature reviewRoberto Depascale, Giulia Del Frate, Michela Gasparotto, et al.
Rheumatology (Oxford, England)|February 26, 2022
Correction to: Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritisMargherita Zen, Enrico Fuzzi, Marta Loredo Martinez, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Rheumatology (Oxford, England)|January 25, 2022
Whipple's aortitisRoberto Depascale, Marco Pizzi, Roberto Padoan
Autoimmunity Reviews|August 25, 2023
When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients?Ioannis Parodis, Roberto Depascale, Andrea Doria, et al.
Best Practice & Research. Clinical Rheumatology|August 25, 2023
Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosusMariele Gatto, Roberto Depascale, Ana Luisa Stefanski, et al.
Mediterranean Journal of Rheumatology|August 28, 2024
Evolving Concepts in Treat-to-Target Strategies for Systemic Lupus ErythematosusDionysis Nikolopoulos, Maria Helena Lourenço, Roberto Depascale, et al.
Journal of Clinical Medicine|June 27, 2024
Modern Management of Pregnancy in Systemic Lupus Erythematosus: From Prenatal Counseling to Postpartum SupportAnna Gamba, Margherita Zen, Roberto Depascale, et al.
Expert Opinion on Biological Therapy|February 25, 2021
Belimumab: a step forward in the treatment of systemic lupus erythematosusRoberto Depascale, Mariele Gatto, Margherita Zen, et al.
Clinical Rheumatology|August 28, 2024
Effectiveness and safety of low dose Rituximab as remission-maintenance treatment for patients with refractory idiopathic inflammatory myopathies: results of a retrospective study from a monocentric cohortAnna Gamba, Roberto Depascale, Elisabetta Zanatta, et al.
International Journal of Molecular Sciences|February 25, 2023
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial HypertensionBeatrice Moccaldi, Laura De Michieli, Marco Binda, et al.
Therapeutic Advances in Musculoskeletal Disease|October 7, 2021
Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren's syndrome: a literature reviewRoberto Depascale, Giulia Del Frate, Michela Gasparotto, et al.
Rheumatology (Oxford, England)|February 26, 2022
Correction to: Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritisMargherita Zen, Enrico Fuzzi, Marta Loredo Martinez, et al.
Pageof 3